Skip to content
Titanium dioxide
Anthelios (titanium dioxide) is a small molecule pharmaceutical. Titanium dioxide was first approved as Anthelios 20 on 2006-10-05.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Anthelios
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Avobenzone
+
Ecamsule
+
Octocrylene
+
Titanium dioxide
Tradename
Company
Number
Date
Products
ANTHELIOS 20L'OréalN-021471 OTC2006-10-05
1 products, RLD, RS
ANTHELIOS 40L'OréalN-022009 OTC2008-03-31
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
derma pella luminous creamunapproved drug other2023-06-20
la roche posay face body anthelios spf 60 melt in milk fast absorbing, velvety finish for all skin types with cell-oc shield xlOTC monograph not final2022-12-29
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
46 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324I25.11—1518
Ischemic strokeD0000832421532—7
Inferior wall myocardial infarctionD056989EFO_1000983——15—6
St elevation myocardial infarctionD000072657——1225
Myocardial infarctionD009203EFO_0000612I21—11215
Acute coronary syndromeD054058EFO_0005672—12115
Percutaneous coronary interventionD062645——12—3
Non-st elevated myocardial infarctionD000072658———112
Coronary diseaseD003327———1—1
Balloon angioplasty coronaryD015906EFO_0003951———1—1
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Unstable anginaD000789EFO_1000985I20.0—11——2
StrokeD020521EFO_0000712I63.9—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Respiratory insufficiencyD012131HP_0002093J96.9—1———1
Embolism and thrombosisD016769—1———1
Viral pneumoniaD011024EFO_0007541J12.9—1———1
Subarachnoid hemorrhageD013345EFO_0000713I6011———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal insufficiencyD051437HP_0000083N191————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTITANIUM DIOXIDE
INN—
Description
Titanium dioxide is a titanium oxide with the formula TiO2. A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications. It has a role as a food colouring.
Classification
Small molecule
Drug classquaternary ammonium derivatives
Image (chem structure or protein)TITANIUM DIOXIDE
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID13463-67-7
RxCUI—
ChEMBL IDCHEMBL1201136
ChEBI ID32234
PubChem CID26042
DrugBank—
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 27,812 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2,369 adverse events reported
View more details